Paragon 28 — Q2 2024 Earnings Presentation
11 slides from Paragon 28's earnings presentation, Aug 8, 2024
Slide 1: 2Q 2024 Earnings Update
1 2Q 2024 Earnings Update August 8, 2024
Slide 2: Forward Looking Statements
2 Copyright ©2024 Paragon 28. All rights reserved. Forward Looking Statements Except for the historical information contained herein, the matters set forth in this document are forward - looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform
Slide 3: Non-GAAP Financial Measures
3 Copyright ©2024 Paragon 28. All rights reserved. Non - GAAP Financial Measures In addition to our results and measures of performance determined in accordance with U . S . GAAP presented in this document, we believe that certain non - GAAP financial measures are useful in evaluating and comparing
Slide 4: 2Q 2024 – Table of Contents
4 Copyright ©2024 Paragon 28. All rights reserved. 2Q 2024 Earnings Update – Table of Contents 2Q 2024 and YTD Highlights 5 2Q 2024 and YTD Revenue Performance 6 Operational Efficiency Strategy 7 Review of Impact Related to Recent Restatements 8 The Global Foot & Ankle Market 9 Continued Strong Prod
Slide 5: 2Q 2024 and YTD Highlights
5 Copyright ©2024 Paragon 28. All rights reserved. 2Q 2024 and YTD Highlights Accelerated growth in 2Q 2024 well above broader market ; Narrowed 2024 Net Revenue guidance Net Revenue Performance & Guidance Key Operational and Financial Details Strategic Highlights Global Net Revenue (YoY Growth): •
Slide 6: 2Q 2024 and YTD Revenue Performance
6 Copyright ©2024 Paragon 28. All rights reserved. 2 Q Net Revenue Performance Highest YoY U.S. Revenue growth rate since 1Q23 driven by sales force expansion and focus on new product launches YTD Net Revenue Performance Narrowed FY 2024 Net Revenue Guidance Consolidated Growth: + 19.6% Reported + 1
Slide 7: Operational Efficiency Strategy
7 Copyright ©2024 Paragon 28. All rights reserved. Operational Efficiency Strategy We believe these initiatives will translate to durable cost savings going forward Streamline organization Manage costs and preserve cash Sustain long - term top - line growth Strategic Intent Key Elements of the Plan
Slide 8: Review of Impact Related to Recent Restatements
8 Copyright ©2024 Paragon 28. All rights reserved. 1Q 2023 2Q 2023 3Q 2023 4Q 2023 FY 2023 1Q 2024 Gross Profit as Previously Reported $43,130 $42,151 $42,389 $45,121 $172,791 $48,896 Gross Margin as Previously Reported 82.9% 82.6% 80.3% 74.5% 79.9% 80.0% Effect of Restatement (from COGS) ($1,323) (
Slide 9: The Global Foot & Ankle Market
9 Copyright ©2024 Paragon 28. All rights reserved. $5.2 Billion $6.9 Billion 2024 2028 The Global Foot & Ankle Market Global Foot & Ankle Market (1) Market Sub - segments (1) Estimated 20 24 Global Market (2) Forefoot 34% Fracture Fixation 30% Flatfoot / PCFD 8% Ankle 11% Charcot 4% Biologics 13% 5%
Slide 10: Continued Strong Product Launch Cadence & Pipeline
10 Copyright ©2024 Paragon 28. All rights reserved. Continued Strong Product Launch Cadence & Pipeline Nine Full Product L aunches and Three Limited Market Release in 2024 YTD (1) Robust Pipeline January 5, 2024 : Grappler® Knotless Anchor System January 30, 2024 : FJ2000 Ρ Power Console and Burr Sy
Slide 11: Smart Bun-Yo-Matic Case Management and Workflow
11 Copyright ©2024 Paragon 28. All rights reserved. Smart Bun - Yo - Matic Case Management and Workflow Bringing unique patient solutions to life with powerful planning combined with precise instrumentation Surgeon accesses the Smart 28 Case Management Portal Select Smart Bun - Yo - Matic CT or X -